RFG - Bristol Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
4,567
+9
+0.2% +$2.1K 0.28% 69
2026
Q1
$1.11M Sell
4,558
-34
-0.7% -$7.92K 0.3% 64
2025
Q4
$950K Sell
4,592
-134
-3% -$26.5K 0.26% 73
2025
Q3
$876K Buy
4,726
+15
+0.3% +$2.57K 0.25% 74
2025
Q2
$720K Sell
4,711
-1,387
-23% -$213K 0.22% 87
2025
Q1
$1.01M Sell
6,098
-316
-5% -$49.4K 0.34% 63
2024
Q4
$928K Buy
+6,414
New +$994K 0.3% 71

Other funds holding JNJ

RFG - Bristol Wealth Advisors's JNJ Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 0.2% in Q2 2026, buying an estimated $2.1K and bringing the position to 4,567 shares worth $1.16M. The position accounts for 0.28% of the portfolio, ranked #69.

RFG - Bristol Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • RFG - Bristol Wealth Advisors held 4,567 shares of Johnson & Johnson worth $1.16M as of Q2 2026.
  • RFG - Bristol Wealth Advisors bought 9 Johnson & Johnson shares in Q2 2026, an estimated $2.1K.
  • Johnson & Johnson made up 0.28% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #69 holding.
  • RFG - Bristol Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.